| scholarly article | Q13442814 |
| P356 | DOI | 10.18632/ONCOTARGET.2840 |
| P8608 | Fatcat ID | release_qs5u3763erge7nvatfludrimwy |
| P932 | PMC publication ID | 4359229 |
| P698 | PubMed publication ID | 25483102 |
| P5875 | ResearchGate publication ID | 269281295 |
| P50 | author | Mark J. Olsen | Q73035272 |
| P2093 | author name string | Yu Li | |
| Xiaoqun Dong | |||
| Qi Tang | |||
| Jack R Wands | |||
| Xuesong Chen | |||
| Qiushi Lin | |||
| Arihiro Aihara | |||
| Chiung-Kuei Huang | |||
| Christina Nadolny | |||
| Gregory Gabriel | |||
| Rolf Carlson | |||
| Waihong Chung | |||
| P2860 | cites work | Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma | Q24562001 |
| Cancer statistics, 2013 | Q27860762 | ||
| Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation | Q28139424 | ||
| Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin | Q28144446 | ||
| Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) β-hydroxylase suppress migration of cholangiocarcinoma cells | Q28201030 | ||
| Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: Relevance to early pregnancy loss | Q28261542 | ||
| Notch signalling: a simple pathway becomes complex | Q29555851 | ||
| Concise review: clinical programs of stem cell therapies for liver and pancreas | Q30555472 | ||
| WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma | Q30571825 | ||
| Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells | Q33828419 | ||
| Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration | Q33944605 | ||
| Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer | Q34023117 | ||
| cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase | Q34249628 | ||
| EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? | Q34504931 | ||
| IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer | Q34958659 | ||
| Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium | Q35103047 | ||
| IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration | Q35144510 | ||
| K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas | Q35992132 | ||
| Signaling networks in human pluripotent stem cells | Q36604800 | ||
| Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. | Q36881446 | ||
| Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia | Q36980230 | ||
| Insulin receptor-overexpressing β-cells ameliorate hyperglycemia in diabetic rats through Wnt signaling activation | Q36997038 | ||
| Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma | Q36997259 | ||
| Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma | Q37068621 | ||
| LRH1 as a driving factor in pancreatic cancer growth | Q37623867 | ||
| Insulin-like growth factor signaling as a therapeutic target in pancreatic cancer | Q37865028 | ||
| Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers | Q37966605 | ||
| Notch signaling in pancreatic cancer: oncogene or tumor suppressor? | Q38094850 | ||
| MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells | Q39117777 | ||
| Canonical wnt signaling is required for pancreatic carcinogenesis | Q39140268 | ||
| Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer | Q39877573 | ||
| Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta | Q39887874 | ||
| Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modules. | Q41593648 | ||
| Pancreatic regeneration in chronic pancreatitis requires activation of the notch signaling pathway | Q42833516 | ||
| Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome | Q43005656 | ||
| P21-activated protein kinase 1 (Pak1) mediates the cross talk between insulin and β-catenin on proglucagon gene expression and its ablation affects glucose homeostasis in male C57BL/6 mice | Q48279087 | ||
| A critical role for notch signaling in the formation of cholangiocellular carcinomas. | Q50945875 | ||
| LRH1 promotes pancreatic cancer metastasis. | Q53055319 | ||
| Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. | Q53631737 | ||
| Pancreatic Cancer | Q54135367 | ||
| Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. | Q54590341 | ||
| Site-directed mutagenesis of residues in a conserved region of bovine aspartyl (asparaginyl) beta-hydroxylase: evidence that histidine 675 has a role in binding Fe2+ | Q71165576 | ||
| Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis | Q73614651 | ||
| Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells | Q74624551 | ||
| Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells | Q82698906 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| P304 | page(s) | 1231-1248 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype | |
| P478 | volume | 6 |
| Q100762137 | 2-Oxoglutarate-dependent dioxygenases in cancer |
| Q35949450 | Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. |
| Q91622958 | Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma |
| Q57112122 | Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation |
| Q98564461 | Aspartate β-hydroxylase as a target for cancer therapy |
| Q36723189 | Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma |
| Q92332826 | Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway |
| Q37485171 | Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas |
| Q90974954 | Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern |
| Q95840325 | Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors |
| Q54967454 | Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies. |
| Q59354375 | Construction and Characterization of Adenovirus Vectors Encoding Aspartate--Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma |
| Q47331366 | Ethanol-Induced White Matter Atrophy Is Associated with Impaired Expression of Aspartyl-Asparaginyl-β-Hydroxylase (ASPH) and Notch Signaling in an Experimental Rat Model |
| Q42366399 | Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma |
| Q54111731 | MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells. |
| Q26784068 | Notch signaling: an emerging therapeutic target for cancer treatment |
| Q90127696 | Prometastatic Secretome Trafficking via Exosomes Initiates Pancreatic Cancer Pulmonary Metastasis |
| Q59329484 | Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update |
| Q37679979 | Role of Notch signaling pathway in pancreatic cancer |
| Q93207896 | Synthesis of Novel Pyridine-carboxylates as Small-Molecule Inhibitors of Human Aspartate/Asparagine-β-Hydroxylase |
Search more.